Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results
Sanuwave Health (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, has scheduled a conference call to discuss their Q1 2025 financial results on Friday, May 9, 2025, at 8:30 AM ET.
Investors can access the call through toll-free (1-800-245-3047) or international (1-203-518-9765) numbers using Conference ID: SANUWAVE. Materials will be available on the company's investor website, and a replay will be accessible until May 30, 2025, using the replay access ID: 11158734.
Sanuwave Health (NASDAQ: SNWV), un fornitore leader di prodotti per la cura delle ferite di nuova generazione approvati dalla FDA, ha programmato una conferenza telefonica per discutere i risultati finanziari del primo trimestre 2025 venerdì 9 maggio 2025 alle 8:30 AM ET.
Gli investitori possono partecipare alla chiamata tramite numeri gratuiti (1-800-245-3047) o internazionali (1-203-518-9765) utilizzando l'ID conferenza: SANUWAVE. I materiali saranno disponibili sul sito web per gli investitori della società e una registrazione sarà accessibile fino al 30 maggio 2025, utilizzando l'ID per l'accesso alla registrazione: 11158734.
Sanuwave Health (NASDAQ: SNWV), un proveedor líder de productos de cuidado de heridas de próxima generación aprobados por la FDA, ha programado una llamada de conferencia para discutir los resultados financieros del primer trimestre de 2025 el viernes 9 de mayo de 2025 a las 8:30 AM ET.
Los inversores pueden acceder a la llamada a través de números gratuitos (1-800-245-3047) o internacionales (1-203-518-9765) usando el ID de conferencia: SANUWAVE. Los materiales estarán disponibles en el sitio web para inversores de la compañía y una repetición estará accesible hasta el 30 de mayo de 2025, utilizando el ID de acceso para la repetición: 11158734.
Sanuwave Health (NASDAQ: SNWV)는 FDA 승인 차세대 상처 치료 제품의 선도 공급업체로, 2025년 1분기 재무 결과를 논의하기 위해 2025년 5월 9일 금요일 오전 8시 30분(동부시간)에 컨퍼런스 콜을 예정했습니다.
투자자들은 무료 전화(1-800-245-3047) 또는 국제 전화(1-203-518-9765)를 통해 컨퍼런스 ID: SANUWAVE를 사용하여 콜에 참여할 수 있습니다. 자료는 회사 투자자 웹사이트에서 제공되며, 2025년 5월 30일까지 재청취가 가능하며 재청취 접속 ID는 11158734입니다.
Sanuwave Health (NASDAQ : SNWV), un fournisseur leader de produits de soins des plaies de nouvelle génération approuvés par la FDA, a programmé une conférence téléphonique pour discuter des résultats financiers du premier trimestre 2025 le vendredi 9 mai 2025 à 8h30 ET.
Les investisseurs peuvent accéder à l'appel via des numéros gratuits (1-800-245-3047) ou internationaux (1-203-518-9765) en utilisant l'ID de conférence : SANUWAVE. Les documents seront disponibles sur le site web des investisseurs de la société et un replay sera accessible jusqu'au 30 mai 2025, avec l'ID d'accès au replay : 11158734.
Sanuwave Health (NASDAQ: SNWV), ein führender Anbieter von FDA-zugelassenen Wundpflegeprodukten der nächsten Generation, hat eine Telefonkonferenz zur Besprechung der Finanzergebnisse für das erste Quartal 2025 für Freitag, den 9. Mai 2025, um 8:30 Uhr ET angesetzt.
Investoren können über gebührenfreie Nummern (1-800-245-3047) oder internationale Nummern (1-203-518-9765) mit der Konferenz-ID: SANUWAVE an der Telefonkonferenz teilnehmen. Materialien werden auf der Investorenseite des Unternehmens verfügbar sein, und ein Replay ist bis zum 30. Mai 2025 mit der Replay-Zugangs-ID: 11158734 abrufbar.
- None.
- None.
EDEN PRAIRIE, Minn., May 05, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8:30 AM (ET) to present its Q1 2025 financial results.
Telephone access to the call will be available by dialing the following numbers:
Participant Dial-in Information
Toll Free: 1-800-245-3047
Toll/International: 1-203-518-9765
Conference ID: SANUWAVE
OR click the link for instant telephone access to the event:
https://viavid.webcasts.com/starthere.jsp?ei=1714486&tp_key=88406b4795
Materials for the conference call will be included on the Company’s website at
www.sanuwave.com/investors.
A replay will be made available through May 30, 2025:
Toll-Free: 1-844-512-2921 or 1-412-317-6671
Replay Access ID: 11158734
About Sanuwave
Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.
Sanuwave's end-to-end wound care portfolio of regenerative medicine products and product candidates help restore the body’s normal healing processes. Sanuwave applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and cardiac/endovascular conditions.
Forward-Looking Statements
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to future financial results, production expectations, plans for future business development activities and expectations regarding the impact of changes in tariff rates. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition and the other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.
Contact:
FAQ
When will Sanuwave (SNWV) report Q1 2025 earnings?
How can I access Sanuwave's Q1 2025 earnings call?
Until when will Sanuwave's Q1 2025 earnings call replay be available?
What is Sanuwave's (SNWV) main business?
